Business Context and Reporting Period
Deep Medicine Acquisition Corp., a Delaware special purpose acquisition company, filed this Form 8-K regarding an event dated November 18, 2022. The filing is associated with Nasdaq-listed Class A common stock and rights. Although the request metadata identifies Trugolf Holdings, Inc., the filing text identifies Deep Medicine Acquisition Corp. as the registrant.
Material Event
The company determined that a special meeting of stockholders would be held in lieu of its 2022 annual meeting on or about December 23, 2022. The definitive proxy statement was expected to provide the meeting time and location.
- Stockholder proposals and director nominations were required to be delivered to the company’s principal executive offices no later than December 1, 2022.
- Proposals and nominations were required to comply with Delaware law, SEC rules and regulations, and the company’s bylaws.
Financial Metrics and Liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial performance metrics.
Guidance, Outlook, Risks and Unusual Items
The filing does not provide financial guidance, operating outlook, risk updates, contingencies, or unusual financial items. Its principal subject is the scheduling of the special stockholder meeting and related nomination deadlines.
Important Facts to Verify
- Verify the registrant identity, because the provided metadata names Trugolf Holdings, Inc., while the filing names Deep Medicine Acquisition Corp.
- Review the definitive proxy statement for the final meeting date, time, location, voting matters, and any proposed transactions.
- Confirm compliance with the December 1, 2022 deadline for stockholder proposals and director nominations.
- Review the company’s bylaws and applicable SEC and Delaware requirements governing proposals and nominations.